Vivos Therapeutics Community

Key Takeaways Rising regulatory costs, digital health trends, and payer resistance threaten revenue growth and profitability for Vivos' device-based treatments. Competitive pressures and innovation in alternative therapies risk making Vivos' offerings obsolete, challenging long-term market relevance and financial sustainability.

Key Takeaways Successful acquisitions and advanced technology position Vivos for rapid national expansion, improved margins, and significant recurring revenue growth. Growing demand for non-invasive sleep apnea treatments and strong insurer support are expected to boost long-term profitability and market share.

Key Takeaways Pivoting from dentist-led distribution to integrating with sleep medicine providers should boost margins, revenue growth, and capture more value from the sleep apnea market. Recent acquisitions and new business model aim for profitability, reduced cash burn, and capitalize on industry consolidation through a scalable expansion strategy.